BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 13.3//EN BEGIN:VTIMEZONE TZID:GMT Standard Time BEGIN:STANDARD DTSTART:20231002T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=10 TZNAME:GMT Standard Time TZOFFSETFROM:+0100 TZOFFSETTO:+0000 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T010000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=1;BYMINUTE=0;BYMONTH=3 TZNAME:GMT Daylight Time TZOFFSETFROM:+0000 TZOFFSETTO:+0100 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Date: 3 December 2019 \;\nTime: 14:00 - 15:30\nSpeakers:&nb sp\;PSI/EFSPI SIG Quantitative Decision-Making members:\n\n\n\n\n V&eac ute\;ronique Robert (Servier)\n Guido Thö\;mmes (Grunenthal)\n O liver Sailer (Boehringer-Ingelheim)\n\nWe performed a survey among pharmac eutical companies\, targeting people with different profiles (statistician s\, non-statisticians and decision-makers) working at different stages of the clinical development (study level\, development level or portfolio lev el). This survey allowed us to analyze which quantitative methods are know n\, which quantitative methods are used (or not)\, what benefit is expecte d from this kind of methods\, and what are the needs for a larger use of q uantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from th e survey and to promote different quantitative methods for decision-making .\nRegistration: \;to register for this free event please \;click here. \;\n\nPlease email \;PSI@mci-group.com \;if you have any questions. DTEND:20191203T153000Z DTSTAMP:20240329T065703Z DTSTART:20191203T140000Z LOCATION: SEQUENCE:0 SUMMARY:PSI Webinar - Overview and awareness about quantitative decision-ma king in drug development UID:RFCALITEM638472922233265136 X-ALT-DESC;FMTTYPE=text/html:
Date: 3 December 2019 \;
\
nTime: 14:00 - 15:30
\nSpeakers: \;PSI/EFSPI SIG
Quantitative Decision-Making members:
\n
\n
\n
We performed a survey among pharmaceutical companies\, targ eting people with different profiles (statisticians\, non-statisticians an d decision-makers) working at different stages of the clinical development (study level\, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known\, which quantitative m ethods are used (or not)\, what benefit is expected from this kind of meth ods\, and what are the needs for a larger use of quantitative methods to s upport decision-making. It permitted to understand the gaps and some of th e issues associated to the use of such methods in drug development. The we binars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.
\nRegistrat ion: \;to register for this free event please \;click here. \;